Journals / Turkish Journal of Medical Sciences / 2005 / Cilt: 35 - Sayı: 3

Current Perspectives in the Pathogenesis and Treatment of Multiple Sclerosis

Pages
131–141
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the past 10 years, 6 therapies that partially treat MS have been developed, and more are likely to be approved in the near future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Multiple sclerosis arises from a combination of genes and environment.
📊
Key Findings & Data:It has abundant clinical symptoms, varied clinical courses, and probably different histopathological subtypes.
💡
Conclusion & Impact:In the past 10 years, 6 therapies that partially treat MS have been developed, and more are likely to be approved in the near future.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Multiple sclerosis · histopathology · treatment

Abstract

Multiple sclerosis arises from a combination of genes and environment. It has abundant clinical symptoms, varied clinical courses, and probably different histopathological subtypes. In the past 10 years, 6 therapies that partially treat MS have been developed, and more are likely to be approved in the near future.

Özet

Multiple sclerosis arises from a combination of genes and environment. It has abundant clinical symptoms, varied clinical courses, and probably different histopathological subtypes. In the past 10 years, 6 therapies that partially treat MS have been developed, and more are likely to be approved in the near future.

🔖

Cite This Article

HAMAMCIOĞLU, K., REDER, A. T. (2022). Current Perspectives in the Pathogenesis and Treatment of Multiple Sclerosis. Turkish Journal of Medical Sciences, Cilt: 35 - Sayı: 3, 131–141. https://ajindex.com/articles/611979

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...